|
Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Cancer > Research and Development |
| 1. |
Dendreon Corp.
|
|
|
Discovers and develops immunologically based therapeutic anticancer products. Includes progress of clinical trials, and data for investors from company based in Seattle, Washington. (Nasdaq: DNDN)
|
| 2. |
Exelixis, Inc.
|
|
|
Genomics-based discovery company focused on development of drugs, crop protection, and plant biotechnology. Overview of research, investor relations and contacts in California and Portland, Oregon. (Nasdaq: EXEL)
|
| 3. |
Onyx Pharmaceuticals, Inc.
|
|
|
Discovers and develops small molecule therapeutics based upon the genetics of human disease, with emphasis on cell growth inhibitors. Includes clinical pipeline, technology overview and investor relations at Richmond, California. (Nasdaq: ONXX)
|
| 4. |
Draxis Health Inc.
|
|
|
Produces radiolabeled compounds for diagnostic and therapeutic use in nuclear medicine and oncology. Includes examples that distinguish infection from inflammation, a peptide based on fibrin, and overview of facilities in Kirkland, Qu?cbec. [English, French and Spanish]
|
| 5. |
Transmolecular, Inc.
|
|
|
Developing treatments in oncology. Includes overview of disease targets, technology, clinical trials, partnering opportunities and contacts for careers in Cambridge, Massachusetts.
|
|
|